Skip to main content

Holiday schedule

Our Patient Service Centers will be closed on Wednesday, January 1, 2025 in observance of New Year's Day. Have a healthy, happy holiday.

Hide
Quest Diagnostics

Comparison of Variants Identified by Next-Generation Sequencing Panels: A 48-Gene Panel for Myeloid Neoplasms and a 35-Gene Panel for Hematologic Neoplasms

AACR 2020: American Association for Cancer Research Annual Meeting 
Virtual [in-person conference canceled], June 22-24, 2020

Comparison of variants identified by next-generation sequencing panels: A 48-gene panel for myeloid neoplasms and a 35-gene panel for hematologic neoplasms

Authors: Rosenthal SH, Chong H, Ma C, Sugganth D, Owen R, Catanese J, Elzinga C, Grupe A, Freitas T, Graham J, Racke F, Lacbawan F

Specialties: oncology, hematology, genetics

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.